GLP-1 Coverage in California: What Chula Vista Patients Should Know (2025) Nov 1, 2025 3 min read Updated: Jan 10 Quick Update (What Changed) California Medi-Cal Rx has announced that GLP-1 medications for weight-loss indications will be excluded from coverage effective January 1, 2026
Therefore, there are insufficient exploratory and repeated studies to support a wide recognition of these molecules for their potential in painful disc treatment
Dont know your BMI
Appropriate patient selection, informed consent, and ongoing monitoring are essential
The most common side effects reported in the clinical trials for liraglutide injection include nausea, diarrhea, vomiting, decreased appetite, dyspepsia and constipation
But the science is pointing in an intriguing direction